PDS Biotechnology Corporation
PDSB
$0.79
$0.022.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.50% | 4.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.78% | -16.28% | |||
| Operating Income | -6.78% | 16.28% | |||
| Income Before Tax | 4.50% | 2.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.50% | -11.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.50% | -11.13% | |||
| EBIT | -6.78% | 16.28% | |||
| EBITDA | -6.79% | 16.31% | |||
| EPS Basic | 6.47% | 1.91% | |||
| Normalized Basic EPS | 6.54% | 13.76% | |||
| EPS Diluted | 6.47% | 1.91% | |||
| Normalized Diluted EPS | 6.54% | 13.76% | |||
| Average Basic Shares Outstanding | 2.11% | 13.28% | |||
| Average Diluted Shares Outstanding | 2.11% | 13.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||